Advertisement

Topics

Metallic nanomolecules could help treat fatal lung disease in the future, notes research

08:10 EDT 5 Jul 2017 | EPM Magazine

New research from Imperial College London, that has recently been published online, examined a novel type of nanoparticle called metal organic frameworks (MOF) as drug carriers for the treatment of pulmonary arterial hypertension (PAH).

Original Article: Metallic nanomolecules could help treat fatal lung disease in the future, notes research

NEXT ARTICLE

More From BioPortfolio on "Metallic nanomolecules could help treat fatal lung disease in the future, notes research"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pulmonary Hypertension
Pulmonary arterial hypertension (PAH) is a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs of affected individuals. Symptoms can range from mild breathles...